Table 3.

Study variables associated with the prevalence of total hip joint replacements

	THR (n = 435)	p value	THR	p value
	Multivariate 1		Multivariate 2
Age (per year)	1.02 (1.00–1.04)	0.02	1.03 (1.01–1.04)	0.01
Female sex	1.42 (1.15–1.76)	0.001	1.52 (1.20–1.92)	<0.0001
BMI (per unit)	1.04 (1.01–1.06)	0.002	1.04 (1.01–1.06)	0.003
Finger length ratio (1–3)	1.05 (0.91–1.24)	0.52	1.05 (0.91–1.22)	0.49
Hand OA severity (0–4)	1.15 (1.07–1.24)	<0.0001	1.15 (1.07–1.24)	<0.0001
BMD (per 10 percent of predicted)	1.05 (1.02–1.08)	0.002	1.05 (1.02–1.08)	0.003
Education (1–4)			1.13 (1.01–1.26)	0.04
Smoking history (1–3)			1.04 (0.89–1.21)	0.67
hs-CRP			1.00 (0.99–1.02)	0.69
Cholesterol			0.99 (0.89–1.11)	0.89
Triglycerides			0.98 (0.83–1.45)	0.82
Statin use			1.10 (0.83–1.45)	0.53
AUC (95 % CI):	0.61 (0.59–0.64)		0.62 (0.59–0.64)
R 2 : Cragg-Uhler (Nagelkerke):	0.03		0.03